Quest Diagnostics Incorporated (DGX) Hits Fresh High: Is There Still Room to Run?

zacks.com · 2026-09-16

Quest Diagnostics (DGX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

TickrTrends take: Quest Diagnostics is trading at levels that TickrTrends currently assesses as overvalued within the Healthcare sector, suggesting the recent high may reflect pricing that has moved ahead of fundamental support. For a valuation-focused reader, the key consideration is whether the company's earnings growth and cash generation can justify the current price level or whether mean reversion becomes a risk. Monitoring the gap between DGX's valuation multiples and sector peers will be important for determining if the recent strength represents sustainable momentum or an opportunity for caution.

Read the full story at zacks.com →